I read that link just now...I had not saw it before...thanks.
7 patients still alive, 6 out of seven on triple combo.
7 patients expired, 3 out of seven on triple combo, two out of three had 5+ cold tumors treated with triple combo.
Thatís 50% disease control rate like I said....but on combo. So it looks like monotherapy Uveal was switched to combos.